Loading...

Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer

BACKGROUND: There is no standard therapy for second-line treatment of gemcitabine-refractory pancreatic cancer patients with poor performance status. A combination of chemotherapy drugs 5-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) or 5-fluorouracil/leucovorin plus nano...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Gastrointest Oncol
Main Authors: Park, Se Jun, Kim, Hyunho, Shin, Kabsoo, Lee, Myung Ah, Hong, Tae Ho
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883178/
https://ncbi.nlm.nih.gov/pubmed/31798782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v11.i11.1021
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!